StockNews.com Begins Coverage on Ampio Pharmaceuticals (NYSE:AMPE)

Analysts at StockNews.com started coverage on shares of Ampio Pharmaceuticals (NYSE:AMPEGet Free Report) in a research report issued on Saturday. The brokerage set a “sell” rating on the stock.

Ampio Pharmaceuticals Price Performance

NYSE:AMPE opened at $0.01 on Friday. Ampio Pharmaceuticals has a 52 week low of $0.00 and a 52 week high of $7.47. The firm has a market capitalization of $11,350.00, a price-to-earnings ratio of 0.00 and a beta of 3.73.

About Ampio Pharmaceuticals

(Get Free Report)

Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.

See Also

Receive News & Ratings for Ampio Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampio Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.